Double Blinded Drug Discovery (DBD2): A New Protected Open Innovation Model Melvin Reichman, LIMR Chemical Genomics Center, speaking at European Lab Automation 2012
Challenges for Stem Cell Bioprocessing - Scale-Up or Scale-Out? Christopher Hewitt, Loughborough University, speaking at Cell Culture 2012
Regulation of Cytochrome P450s and Nuclear Receptor by microRNAs and its Toxicological Implications Tsuyoshi Yokoi, Kanazawa University, speaking at ADME & Predictive Toxicology Europe
Enhancing Homing Permeability and Retention of Stem Cells by Pulsed Focused Ultrasound Dr. Joseph A. Frank, National Institutes of Health, speaking at Stem Cells 2012.
Defence and Adaptation in Drug-Mediated Liver Toxicity Christopher Goldring, University of Liverpool, speaking at ADME & Predictive Toxicology Europe 2012
Improvement of Cell Culture Technology for Primary Cells and Stem Cell Manipulation Dr Veit Bergendahl, Miltenyi Biotec GmbH, speaking at Cell Culture 2012
Companies in Translation with CIRM Dr Alan Trounson, California Institute for Regenerative Medicine, speaking at Stem Cells 2012
The Bavarian Red Cross Blood Donor BioBank - the First Successful Combination of Blood Donation and Biobanking Christine Zoglmeier, Bavarian Red Cross Blood Donor BioBank, speaking at World Biobanking Summit 2011.
Wither Biobanking for Cancer? Building our Reserves or, a Spending Spree? Malcolm Mason, Director of the Wales Cancer Bank, speaking at World Biobanking Summit 2011.